Emer Leahy is Director of Pasithea Therapeutics Corp.. Currently has a direct ownership of 33,333 shares of KTTA, which is worth approximately $23,999. The most recent transaction as insider was on Nov 28, 2025, when has been sold 33,333 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $24,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.3K
n/a 3M change
n/a 12M change
Total Value Held $23,999

Emer Leahy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 28 2025
BUY
Grant, award, or other acquisition
$24,999 $0.75 p/Share
33,333 Added 50.0%
33,333 Common Stock

Also insider at

INTS
INTENSITY THERAPEUTICS, INC. Healthcare
EL

Emer Leahy

Director
Miami Beach, FL

Track Institutional and Insider Activities on KTTA

Follow Pasithea Therapeutics Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTTA shares.

Notify only if

Insider Trading

Get notified when an Pasithea Therapeutics Corp. insider buys or sells KTTA shares.

Notify only if

News

Receive news related to Pasithea Therapeutics Corp.

Track Activities on KTTA